key: cord-0857309-kt0gwxf3 authors: Dong, Lianhua; Zhou, Junbo; Niu, Chunyan; Wang, Quanyi; Pan, Yang; Sheng, Sitong; Wang, Xia; Zhang, Yongzhuo; Yang, Jiayi; Liu, Manqing; Zhao, Yang; Zhang, Xiaoying; Zhu, Tao; Peng, Tao; Xie, Jie; Gao, Yunhua; Wang, Di; Dai, Xinhua; Fang, Xiang title: Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR date: 2020-10-27 journal: Talanta DOI: 10.1016/j.talanta.2020.121726 sha: 0877b94d207ffa6e3e493f9581f91093cf81f266 doc_id: 857309 cord_uid: kt0gwxf3 The outbreak of COVID-19 caused by a novel Coronavirus (termed SARS-CoV-2) has spread to over 210 countries around the world. Currently, reverse transcription quantitative qPCR (RT-qPCR) is used as the gold standard for diagnosis of SARS-CoV-2. However, the sensitivity of RT-qPCR assays of pharyngeal swab samples are reported to vary from 30% to 60%. More accurate and sensitive methods are urgently needed to support the quality assurance of the RT-qPCR or as an alternative diagnostic approach. A reverse transcription digital PCR (RT-dPCR) method was established and evaluated. To explore the feasibility of RT-dPCR in diagnostic of SARS-CoV-2, a total of 196 clinical pharyngeal swab samples from 103 suspected patients, 77 close contacts and 16 supposed convalescents were analyzed by RT-qPCR and then measured by the proposed RT-dPCR. For the 103 fever suspected patients, 19 (19/25) negative and 42 (42/49) equivocal tested by RT-qPCR were positive according to RT-dPCR. The sensitivity of SARS-CoV-2 detection was significantly improved from 28.2% by RT-qPCR to 87.4% by RT-dPCR. For 29 close contacts (confirmed by additional sample and clinical follow up), 16 (16/17) equivocal and 1 negative tested by RT-qPCR were positive according to RT-dPCR, which is implying that the RT-qPCR is missing a lot of asymptomatic patients. The overall sensitivity, specificity and diagnostic accuracy of RT-dPCR were 91%, 100% and 93 %, respectively. RT-dPCR is highly accurate method and suitable for detection of pharyngeal swab samples from COVID-19 suspected patients and patients under isolation and observation who may not be exhibiting clinical symptoms. In late December 2019, a number cases of pneumonia infection were reported in Wuhan, Hubei Province, China. It was officially named Coronavirus disease by the World Health Organization (WHO) and has since spread to 210 countries around the world [1, 2] . The pathogen causing the outbreak of disease was identified as a novel Coronavirus (termed SARS-CoV-2), belonging to the family Coronaviridae, order Nidovirales, all of which are enveloped, non-segmented positive-sense RNA viruses [3, 4] . According to the WHO and the Chinese Center for Disease Control and Prevention (CDC), the current gold standard for the diagnosis of SARS-CoV-2 infection is based on reverse transcription quantitative PCR (RT-qPCR). However, RT-qPCR is reported to have issue of false negative rates for pharyngeal swab samples [5] and there were 3% of patients who had negative RT-qPCR test results at initial presentation while chest CT checks indicated typical symptoms of viral pneumonia [6] . In order to identify and hospitalize COVID-19 patients in time, more sensitive and accurate tests are required. Digital PCR (dPCR) is a technology which partitions nucleic acid molecules into a large number of small reactions and acquires amplification data for each partition at the endpoint based on the intensity of fluorescence [7] [8] [9] . Quantification is performed by applying Poisson statistics to the proportion of the negative partitions. dPCR can offer greater precision than qPCR and is far simpler to use for copy number quantification due the binary nature in which the partitions are counted as positive or negative. Additionally, dPCR is more tolerant of PCR inhibition compared with qPCR due to partitioning and because it is an end-point PCR measurement and consequently less dependent on high PCR efficiency [10, 11] . In this study, we established one step RT-dPCR method for detection of open reading frame 1ab (ORF1ab) , nucleocapsid protein (N) and envelope protein (E) gene of SARS-CoV-2. Moreover, we compared RT-qPCR and RT-dPCR on 196 clinical samples and found RT-dPCR can significantly improve the sensitivity and diagnostic accuracy of Coronavirus disease (COVID-19). Three in vitro transcribed RNAs were used as templates to develop RT-dPCR assays. The genome sequence of 2019-nCoV (GenBank No. NC_045512) were download from NCBI. Sequences containing ORF1ab (13201-15600), E (25381-26520), and N (28261-29820) were used to order synthetic genes from BGI (Beijing, China). All the detail information was in the supplemental information. Three assays for gene targets of N,ORF1ab and E of the SARS-CoV-2 were optimized on QX200 digital PCR platform [12, 13] . Three different commercial RT-qPCR kits (H&R from Shanghai Huirui Biotechnology Co., Ltd, BioGerm from Shanghai BioGerm Medical Biotechnology and Daan from Daan Gene Co., Ltd) were used for the detection. The detail of RT-dPCR and RT-qPCR was in the supplemental information. J o u r n a l P r e -p r o o f To establish the limit of blank (LoB) [14] , 60 blank measurements were obtained from 3 blank samples on three days. 70 to 76 measurements from 4-5 samples with low concentration (1 to 3 cp/reaction) were used to determine the limit of detection (LoD) according to the CLSI guideline of EP17-A [15] . The linear range was investigated by varying the mean copy number per droplet, denoted as λ [16] . The precision or relative error of RT-dPCR is related to λ because of RT-dPCR relies on the Poisson statistics to account for droplets with multiple molecules [17] . The upper limit of the linearity was 7.8 copies/partition tested by the N gene assay. To determine the lower limit of all three assays, serial dilutions of each RNA transcript in a human total RNA background were prepared (Table S1 ). The measured targets matched the anticipated values in each tested interval. A good linearity (0.93